Contract pharmaceutical fermentation services to grow at 5.9% CAGR through 2026: Fact.MR.

Fact.MR's report on the global contract pharmaceutical fermentation services market highlights steady growth in 2021. The increasing adoption of advanced biotechnology and growing collaborations between pharmaceutical companies and fermentation services are driving market expansion.

The study also reveals that drug commercialization through contract manufacturing organizations is fueling bulk production, while rising R&D activities further accelerate the market's growth. Additionally, the increasing prevalence of diseases such as cancer, diabetes, cardiovascular conditions, rheumatoid arthritis, and hemophilia is boosting the demand for efficient drug development, supporting the growth of contract pharmaceutical fermentation services.

The pharmaceutical industry is rapidly evolving, with manufacturing companies facing challenges such as high market growth, shifting regulations, new therapies, and increasing digitization.

To tackle these challenges, pharmaceutical manufacturers are increasingly adopting existing manufacturing equipment and outsourcing production to contract service providers. Microbial fermentation, a core process for producing various pharmaceutical products, has evolved significantly in recent years.

As a result, many pharmaceutical companies are now deriving active pharmaceutical ingredients (APIs) from fermented products, driving demand for contract pharmaceutical fermentation services to meet bulk supply needs. The growing use of microbial fermentation for producing therapeutic proteins, monoclonal antibodies, peptides, and intermediates has become an efficient economic solution for meeting production demands and ensuring timely market delivery.

This increasing reliance on fermentation processes, along with the expanding pharmaceutical industry, is expected to propel the growth of the contract pharmaceutical fermentation services market in the coming years.

The pharmaceutical industry is rapidly evolving, with a continuous improvement in understanding diseases at the molecular level. This growing knowledge is driving the demand for faster drug production.

To meet the increasing production needs, many pharmaceutical companies are collaborating with contract pharmaceutical fermentation service providers to bring innovative molecules to market. The rising prevalence of diseases such as cancer, diabetes, anemia, and rheumatoid arthritis is expected to further boost demand for pharmaceutical products aimed at disease management.

The widespread need for therapies and treatments is fueling the demand for quicker drug production processes. Contract pharmaceutical fermentation service providers help reduce time-to-market for key pharmaceutical products by offering collaborative platforms for efficient drug development and analytical services.

This trend of time-efficient drug production is expected to drive significant growth in the contract pharmaceutical fermentation services market over the forecast period.

Key Segmentation of the Contract Pharmaceutical Fermentation Services Market:

1. By Service Type:

   • Fermentation Development Services: Includes process development, optimization, and scale-up for fermentation-based production of pharmaceutical products.
   • Fermentation Production Services: Involves large-scale production and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and other related products.
   • Analytical and Testing Services: Includes quality control, stability testing, and compliance with regulatory standards.

2. By End-User:

   • Pharmaceutical Companies: Large and small pharmaceutical companies outsourcing fermentation services for production of APIs, intermediates, and therapeutic proteins.
   • Biotechnology Companies: Companies involved in biopharmaceuticals and biologics that use fermentation for producing biologic drugs, monoclonal antibodies, and peptides.
   • Contract Manufacturing Organizations (CMOs): Third-party organizations providing manufacturing services to pharmaceutical and biotech firms.

3. By Fermentation Type:

   • Microbial Fermentation: Utilizes microorganisms such as bacteria, yeast, and fungi for the production of drugs and other pharmaceutical ingredients.
   • Cell Culture-Based Fermentation: Involves using mammalian cells or other cell types for the production of therapeutic proteins and antibodies.

4. By Application:

   • Therapeutic Proteins: Includes monoclonal antibodies, enzymes, and growth factors used in treatments for various diseases.
   • Vaccines: Fermentation processes used in the production of vaccines and related biologics.
   • Peptides and Polypeptides: Used in hormone therapies, cancer treatments, and other specific disease management.
   • Other Pharmaceutical Products: Includes antibiotics, vitamins, amino acids, and other drug compounds.

5. By Region:

   • North America: Dominated by the U.S. and Canada, where pharmaceutical companies and contract manufacturers collaborate extensively.
   • Europe: Includes major pharmaceutical hubs like Germany, France, and the U.K. with a focus on innovation and regulatory compliance.
   • Asia Pacific: Rapidly growing due to low-cost manufacturing and increasing collaborations in countries like China and India.
   • Latin America: Growing pharmaceutical sector, especially in Brazil and Mexico.
   • Middle East and Africa: Developing market with expanding pharmaceutical manufacturing capabilities.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog